Camp4 Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Camp4 Therapeutics stock have an average target of 16.23, with a low estimate of 6.90 and a high estimate of 23. The average target predicts an increase of 111.32% from the current stock price of 7.68.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$6.90	$16.23	$18	$23
Change	-10.16%	+111.32%	+134.37%	+199.47%

Analyst Ratings

The average analyst rating for CAMP stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	1	1	1	1	1	0
Buy	0	0	0	0	0	4
Hold	2	2	2	2	2	0
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	4	4	4	4	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Myles Minter William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Nov 5, 2024
Mani Foroohar Leerink Partners	Leerink Partners	Buy Initiates $17	Buy	Initiates	$17	+121.35%	Nov 5, 2024
Eric Joseph JP Morgan	JP Morgan	Buy Initiates $23	Buy	Initiates	$23	+199.47%	Nov 5, 2024
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Initiates $18	Buy	Initiates	$18	+134.37%	Nov 5, 2024
Jerry Revich Goldman Sachs	Goldman Sachs	Strong Sell Maintains $8.05 → $6.9	Strong Sell	Maintains	$8.05 → $6.9	-10.16%	Jan 11, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.